R. Vimercati

876 citations
26 papers · 437 · h-index 11

Impact in

  • Hematology top 5%
    • Hematopoietic Stem Cell Transplantation
    • Chronic Myeloid Leukemia Treatments
    • Acute Myeloid Leukemia Research
  • Genetics top 5%
    • Chronic Lymphocytic Leukemia Research

Papers in

    • Chronic Lymphocytic Leukemia Research 11
    • Hematopoietic Stem Cell Transplantation 5
    • Chronic Myeloid Leukemia Treatments 4
    • Acute Myeloid Leukemia Research 3

R. Vimercati

23 papers receiving 415 citations

Peers

R. Vimercati
Comparison fields: 5 of 43
  • Hematology 265
  • Genetics 172
  • Pathology and Forensic Medicine 102
  • Oncology 128
  • Immunology 60
Replace Michihiko Masuda with:
Michihiko Masuda Japan
R Cerri Italy
Xavier Cahu France
M Shtalrid Israel
R Spanedda Italy
A. Benger Canada
L Vellekoop United States
Javier Grau Spain
CE Litz United States
F. Dreyfus France
R. Vimercati relative to Michihiko Masuda Japan Michihiko Masuda's profile →
Citations per field
00.5×1.6×
Michihiko Masuda · 1×
Citations per year

Countries citing papers authored by R. Vimercati

Since Specialization
Citations

This map shows the geographic impact of R. Vimercati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Vimercati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Vimercati more than expected).

Fields of papers citing papers by R. Vimercati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Vimercati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Vimercati. The network helps show where R. Vimercati may publish in the future.

Co-authors

The 25 scholars most cited alongside R. Vimercati, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with R. Vimercati Line = papers co-authored together R. Vimercati links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Collection of 'normal' blood repopulating cells during early hemopoietic recovery after intensive conventional chemotherapy in chronic myelogenous leukemia.
199391
2 198162
3 198552
4
Lack of in vitro colony (CFUC) formation and myelosuppressive activity in patients with severe aplastic anemia after autologous hematologic reconstitution.
198032
5
Fludarabine in untreated and previously treated B-CLL patients: a report on efficacy and toxicity.
199429
6 199629
7
Fludarabine in combination with cyclophosphamide or with cyclophosphamide plus mitoxantrone for relapsed or refractory low-grade non-Hodgkin's lymphoma.
200124
8
Multiple myeloma in the elderly: clinical features and response to treatment in 113 patients.
199622
9 199822
10
High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
199619
11 198114
12 199710
13 20047
14 19997
15 19913
16 19893
17
Major ABO incompatible bone marrow transplantation.
19803
18 19822
19
[Induction and consolidation combination chemotherapy with 8 drugs (L-10 protocol) for acute lymphoblastic leukemia (author's transl)].
19812
20 20061

About R. Vimercati

R. Vimercati is a scholar working on Genetics, Hematology, Pathology and Forensic Medicine, Oncology and Public Health, Environmental and Occupational Health, having authored 26 papers that have together received 437 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (10 papers), Acute Lymphoblastic Leukemia research (6 papers), Hematopoietic Stem Cell Transplantation (5 papers), Chronic Myeloid Leukemia Treatments (4 papers), Viral-associated cancers and disorders (4 papers), Acute Myeloid Leukemia Research (3 papers) and Cancer Treatment and Pharmacology (3 papers). The work is most often cited by research in Hematology (265 citations), Genetics (172 citations), Pathology and Forensic Medicine (102 citations), Oncology (128 citations) and Immunology (60 citations). R. Vimercati has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Marina Podestà, Gino Santini, E Damasio, Francesco Frassoni, Marco Risso, Angelo Michele Carella, Carella Am, Ester Pungolino, Mauro Spriano and S Nati. Their work appears in journals such as Blood, British Journal of Haematology, Leukemia Research, Cancer and European Journal Of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact